Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,207 public trials 376 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Active, Not Recruiting

MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma

NCT02385214

Conditions
Cutaneous Melanoma by AJCC V7 Stage, Melanoma, Neoplasms, +10 more
Locations
  • Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
  • Melanoma Institute Australia - Poche Centre North Sydney, New South Wales, Australia
  • Gold Coast Melanom Clinic Coolangatta, Queensland, Australia
  • Peter MacCallum Cancer Centre Division of Cancer Surgery Melbourne, Victoria, Australia
View all 20 locations
View Trial Details
Active, Not Recruiting

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

NCT05215574

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +83 more
Locations
  • NGM Clinical Study Site Gilbert, Arizona, United States
  • NGM Clinical Study Site Los Angeles, California, United States
  • NGM Clinical Study Site Sarasota, Florida, United States
  • NGM Clinical Study Site Tampa, Florida, United States
View Trial Details
Active, Not Recruiting

Neoadjuvant L19IL2/L19TNF- Pivotal Study

NCT02938299

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • Hôpital de la Timone Marseille, France
  • Hôpital Universitaire de Nantes Nantes, France
  • Institut Gustave Roussy Villejuif, France
  • Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden Dresden, Germany
View all 22 locations
View Trial Details
Active, Not Recruiting

ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors

NCT04205227

Conditions
Adnexal Diseases, Cancer, Digestive System Diseases, +30 more
Locations
  • Cedars Sinai-The Angeles Clinic Los Angeles, California, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Border Medical Oncology Albury, New South Wales, Australia
  • Blacktown Oncology Blacktown, New South Wales, Australia
View Trial Details
Active, Not Recruiting

A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

NCT05867303

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +48 more
Locations
  • ICON Cancer Centre Wesley Auchenflower, Queensland, Australia
  • Southern Oncology Clinical Research Unit Bedford Park, South Australia, Australia
  • Cabrini Hospital Malvern Malvern, Victoria, Australia
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details
Active, Not Recruiting

Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies

NCT05013099

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +40 more
Locations
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • Providence Saint John's Cancer Institute Santa Monica, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

Adjuvant Nivolumab Treatment in Stage II (IIA, IIB, IIC) High-risk Melanoma

NCT04309409

Conditions
Malignant Melanoma Stage II, Melanoma, Neoplasms, +10 more
Locations
  • Universitätsklinikum Würzburg - Klinik für Dermatologie, Venerologie und Allergologie Würzburg, Bavaria, Germany
  • Universitätsmedizin Rostock -Klinik und Poliklinik für Dermatologie und Venerologie Rostock, Mecklenburg-Vorpommern, Germany
  • Universitätsklinikum Augsburg, Campus Süd Augsburg, Germany
  • St. Josef-Hospital - Dermatologische Studienambulanz Bochum, Germany
View all 20 locations
View Trial Details

Related conditions